• Immunosuppressive treatment for proliferative lupus nephritis 

      Tunnicliffe, David J; Palmer, SC; Henderson, L; Henderson, L; Masson, P; Craig, JC; Tong, A; Singh-Grewal, D; Flanc, RS; Roberts, MA; Webster, AC; Strippoli, GFM
      Published 2018-01-01
      Background Cyclophosphamide, in combination with corticosteroids, has been first-line treatment for inducing disease remission for proliferative lupus nephritis, reducing death at five years from over 50% in the 1950s and ...
      Open Access
      Article
    • Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials 

      Palmer, SC; Tunnicliffe, David J; Singh-Grewal, D; Mavridis, D; Tonelli, M; Johnson, DW; Craig, JC; Tong, A; Strippoli, GFM
      Published 2017-03-01
      Background: Intravenous (IV) cyclophosphamide has been first-line treatment for inducing disease remission in lupus nephritis. The comparative efficacy and toxicity of newer agents such as mycophenolate mofetil (MMF) and ...
      Open Access
      Article, Letter